Nutritional implications in vascular endothelial cell metabolism

Journal of the American College of Nutrition

Volumn 15, Issue 4, 1996, Pages 345-358

  Hennig, Bernhard ^a   Toborek, Michal ^b   McClain, Craig J ^b   Diana, John N ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Antioxidants; Atherosclerosis; Barrier function; Endothelial cells; Fatty acids; Inflammatory cytokines; Nutrition; Oxidative stress; Transcription factors

Indexed keywords

ATHEROSCLEROSIS; CELL MEMBRANE FLUIDITY; CELL METABOLISM; EXTRACELLULAR MATRIX; FAT INTAKE; HUMAN; INFLAMMATION; LIPID COMPOSITION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; REVIEW; VASCULAR ENDOTHELIUM;

ANTIOXIDANTS; ARTERIOSCLEROSIS; CYTOKINES; DIETARY FATS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; GLUTATHIONE; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEOGLYCANS; VITAMIN E; ZINC;

EID: 0029790726     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.1996.10718609     Document Type: Article

References (138)

1. Hajjar DP, Nicholson AC: Atherosclerosis. Amer Sci 83:460-467, 1995.
2. Munro JM, Cotran RS: The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest 58:249-261, 1988.
3. Haudenshild CC: Pathogenesis of atherosclerosis: state of the art. Cardiovasc Drugs Ther 4:993-1004, 1990.
4. laffe EA: Cell biology of endothelial cells. Hum Pathol 18:234-239, 1987.
5. Fajardo LF: The complexity of endothelial cells. Arn 1 Clin Pathol 92:241-250, 1989.
6. Davies MG, Hagen PO: The vascular endothelium. A new horizon. Ann Surg 218:593-609, 1993.
7. Ross R: The pathogenesis of atherosclerosis-an update. N Engl J Med 314:488-500, 1986.
8. Norum KR: Dietary fat and blood lipids. Nutr Rev 50:30-37, 1992.
9. Mahley RW: Dietary fat, cholesterol, and accelerated atherosclerosis. Atherosclerosis Rev 5:1-34, 1979.
10. Connor WE, Connor SL: Diet, atherosclerosis and fish oil. Adv Intern Med 35:139-172, 1990.
11. Hennig B, Alvarado A: Nutrition and endothelial cell integrity: Implications in atherosclerosis. Prog Food Nutr Sci 17:119-157, 1993.
12. Hennig B, Toborek M, Cader AA, Decker EA: Nutrition, endothelial cell metabolism and atherosclerosis. Crit Rev Food Sci Nutr 34:253-282, 1994.
13. DiCorieto PE, Chisolm GM: Participation of the endothelium in the development of the atherosclerotic plaque. Prog Lipid Res 25:365-374, 1986.
14. Zilversmit DB: Role of triglyceride-rich lipoproteins in atherosclerosis. Ann NY Acad Sci 275:138-144, 1976.
15. Hennig B, Shasby DM, Fulton AB, Spector AA: Exposure to free fatty acid increases the transfer of albumin across cultured endothelial monolayers. Arteriosclerosis 4:489-497, 1984.
16. Hennig B, Shasby DM, Spector AA: Exposure to fatty acid increases human low density lipoprotein transfer across cultured endothelial monolayers. Circ Res 57:776-780, 1985.
17. Hennig B, Alvarado A, Ramasamy S, Boissonneault GA, Decker E, Means Wl: Fatty acid induced disruption of endothelial barrier function in culture. Biochem Arch 6:409-417, 1990.
18. Hennig B, Enoch C, Chow CK: Linoleic acid hydroperoxide increases the transfer of albumin across cultured endothelial monolayers. Arch Biochem Biophys 248:353-357, 1986.
19. Hennig B, Ramasamy S, Alvarado A, Shantha NC, Boissonneault GA, Decker EA, Watkins BA: Selective disruption of endothelial barrier function in culture by pure fatty acids and fatty acids derived from animal and plant fats. J Nutr 123:1208-1216,1993.
20. Loustarinen R, Boberg M, Saldeen T: Fatty acid composition in total phospholipids of human coronary arteries in sudden cardiac death. Atherosclerosis 99:187-193, 1993.
21. Hodgson JM, Wahlqvist ML, Boxall JA, Balazs NO: Can linoleic acid contribute to coronary artery disease? Am J Clin Nutr 58: 228-234, 1993.
22. Hennig B, Watkins BA: Linoleic acid and linolenic acid: effect on permeability properties of cultured endothelial cell monolayers. Am J Clin Nutr 49:301-305, 1989.
23. Denning GM, Figard PH, Kaduce TL, Spector AA: Role of triglycerides in endothelial cell arachidonic acid metabolism. J Lipid Res 24:993-1001, 1983.
24. Vossen RCRM, Feijge MAH, Heemskerk JWM, van Dam-Mieras MCE, Homstra G, Zwaal RFA. Long-term fatty acid modification of endothelial cells: implications for arachidonic acid distribution in phospholipid classes. J Lipid Res 34:409-420, 1993.
25. Hart CM, Andreoli SP, Patterson CE, Garcia JGN. Oleic acid supplementation reduces oxidant-mediated dysfunction of cultured porcine pulmonary artery endothelial cells. J Cell Physiol 156:24-34, 1993.
26. Spector AA, Kaduce TL, Hoak JC, Fry GL: Utilization of arachidonic and linoleic acids by cultured human endothelial cells. J Clin Invest 68:1003-1011, 1981.
27. Cader AA, Butterfield DA, Watkins BA, Chung BH, Hennig B: Electron spin resonance studies of fatty acid-induced alterations in membrane fluidity in cultured endothelial cells. Int J Biochem Cell Biol 27:66-73, 1995.
28. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol: modification of low density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924, 1989.
29. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D: Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 81:3883-3887, 1984.
30. Witztum JL: Role of oxidised low density lipoprotein in atherogenesis. Br Heart J 69:(Suppl) S12-S18, 1993.
31. Hirarnatsu K, Rosen H, Heinecke JW, Wolfbauer G, Chait A: Superoxide initiates oxidation of low density lipoprotein by human monocytes. Arteriosclerosis 7:55-60, 1986.
32. Parthasarathy S, Wieland E, Steinberg D: A role of endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc Natl Acad Sci USA 86:1046-1050, 1989.
33. Morel DW, DiCorleto PE, Chisholm GM: Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 4:357-364, 1984.
34. Navab M, lmes SS, Harna SY, Hough GP, Ross LA, Bork RW, Valente AJ, Berliner JA, Drinkwater DC, Laks H, Fogelman AM: Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest 88:2039-2046, 1991.
35. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, Lusis AJ: Induction of endothelial cell expression of granulocyte and macrophage colony stimulating factors by modified low density lipoprotein. Nature 244:254-257, 1990.
36. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD: Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low density lipoproteins. Nature 344: 160-162,1990.
37. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Barnshad B, Esterson M, Fogelman MA: Minimally modified LDL stimulates monocyte endothelial interaction. J Clin Invest 85: 1260-1266, 1990.
38. Reaven P, Parthasarathy S, Grasse BJ, Miller E, Almazan F, Mattson FH, Khoo JC, Steinberg D, Witztum JL: Feasibility of using an oleate-rich diet to reduce the susceptibility of lowdensity lipoprotein to oxidative modification in humans. Am J Clin Nutr 54:701-706, 1991.
39. Hennig B, Toborek M, Boissonneault GA, Shantha NC, Decker EA, Oeltgen PR: Animal and plant fats selectively modulate oxidizability of rabbit LDL and LDL-mediated disruption of endothelial barrier function. J Nutr 125:2045-2054, 1995.
40. Sirnth LL: Another cholesterol hypothesis: cholesterol as antioxidant. Free Radical Bioi Med 11:47-41, 1991.
41. Cosgrove JP, Church DF, Pryor WA: The kinetics of the autooxidation of polyunsaturated fatty acids. Lipids 22:299-304, 1987.
42. Toborek M, Barger SW, Mattson MP, Barve S, McClain CJ, Hennig B: Linoleic acid and TNF-a cross-amplify oxidative injury and dysfunction of endothelial cells. J Lipid Res 37:123-135, 1996.
43. Mattson, MP, Barger SW, Begley JG, Mark RJ: Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Meth Cell BioI 46:187-215, 1995.
44. Hennig B, Wang Y, Boissonneault GA, Alvarado A, Glauert HP: Effects of fatty acid enrichment on the induction of peroxisomal enzymes in cultured porcine endothelial cells. Biochem Arch 6:141-146, 1990.
45. Alexander-North LS, North JA, Kiminyo KP, Buettner GR, Spector AA: Polyunsaturated fatty acids increase lipid radical formation induced by oxidant stress in endothelial cells. J Lipid Res 35:1773-1785, 1994.
46. Hennig B, Chow CK: Lipid peroxidation and endothelial cell injury: implications in atherosclerosis. Free Radical Biol Med 4:99-106, 1988.
47. Tamura H, Shibamoto T: Gas chromatographic analysis of malonaldehyde and 4-hydroxy-2-(E)-nonenal produced from arachidonic acid and linoleic acid in a lipid peroxidation model system. Lipids 26:170-173, 1991.
48. Rarnasarny S, Boissonneault GA, Decker EA, Hennig B: Linoleic acid-induced endothelial cell injury: role of membrane-bound enzyme activities and lipid oxidation. J Biochem Toxicol 6:29-35, 1991.
49. Mattson MP, Scheff SW: Endogenous neuroprotection factors and traumatic brain injury: mechanisms of action and implications for therapy. J Neurotrauma 11:3-33, 1994.
50. Yia-Herttuala S: Gene expression in atherosclerotic lesions. Hertz 17:270--276, 1992.
51. Collins T: Endothelial nuclear factor-xfl and the initiation of the atherosclerotic lesion. Lab Invest 68:499-508, 1993.
52. Pang XP, Ross NS, Park M, Juillard GJ, Stanley TM, Hershman JM: Tumor necrosis factor-alpha activates nuclear factor kappa B and induces manganous superoxide dismutase and phosphodiesterase mRNA in papillary thyroid carcinoma cells. J Bioi Chern 267:12826-12830, 1992.
53. Schreck R, Albennann K, Baeuerle PA: Nuclear factor KB: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun 17:221-237, 1992.
54. Hennig B, Toborek M, Joshi-Barve S, Barger SW, Barve S, Mattson MP, McClain CJ: Linoleic acid activates NF-KB and induces NF-KB-dependent transcription in cultured endothelial cells. Am J Clin Nutr 63:322-328, 1996.
55. Thanos D, Maniatis T: NF-KB: A lesson in family values. Cell 80:529-532, 1995.
56. Maran A, Maitra RK, Kumar A, Dong B, Xiao W, Li G, Williams BRG, Torrence PF, Silverman RH: Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras. Science 265:789-792, 1994.
57. Kolesnick R, Golde DW: The sphingomyelin pathway in tumor necrosis factor and interleukin-l signaling. Cell 77:325-328, 1994.
58. Droge W, Schulze-Osthoff K, Mihm S, Galter D, Schenk H, Eck H-P, Roth S, Gmynder H: Functions of glutathione disulfide in immunology and immunopathology. FASEB J 8:1131-1138, 1994.
59. Reiner G, Oliver M, Skamene E, Radzioch D: Induction of tumor necrosis factor alpha gene expression by lipoprotein lipase requires protein kinase C activation. J Lipid Res 35:1413-1421, 1994.
60. Parhami F, Fang ZT, Fogelman AM, Andalibi A, Territo MC, Berliner JA: Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest 92:471-478, 1993.
61. Meichle A, Schutze S, Hensel G, Brunsing D, Kronke M: Protein kinase C-independent activation of nuclear factor KB by tumor necrosis factor. J Biol Chern 265:8339-8343, 1990.
62. Faruqi RM, DiCorleto PE: Mechanisms of monocyte recruitment and accumulation. Br Heart J 69:(1 Suppl) S19-S29, 1993.
63. Albelda SM, Smith CW, Ward PA: Adhesion molecules and inflammatory injury. FASEB J 8:504-512, 1994.
64. Tracey KJ, Cerami A: Tumor necrosis factor and regulation of metabolism in infection: role of systemic versus tissue levels. Proc Soc Exp Bioi Med 200:233-239, 1992.
65. Rus HG, Niculescu F, Vlaicu R: Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis 89:247-254, 1991.
66. Vaddi K, Nicolini FA, Mehta P, Mehta JL: Increased secretion of tumor necrosis factor-a and interferon-v by mononuclear leukocytes in patients with ischemic heart disease. Relevance in superoxide anion generation. Circulation 90:694-699, 1994.
67. Toborek M, Barger SW, Mattson MP, McClain CJ, Hennig B: Role of glutathione redox cycle in TNF-mediated endothelial cell dysfunction. Atherosclerosis 117:179-188, 1995.
68. Maziere C, Auclair M, Maziere JC: Tumor necrosis factor enhances low density lipoprotein oxidative modification by monocytes and endothelial cells. FEBS Lett 338:43-46, 1994.
69. Hanemaaijer R, Koolwijk P, le Clercq L, de Vree WJ, van Hinsbergh VW: Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin I and phorbol ester. Biochem J 296:803-809, 1993.
70. Renier G, Olivier M, Skamene E, Radzioch D: Induction of tumor necrosis factor a gene expression by lipoprotein lipase. J Lipid Res 35:271-278, 1994.
71. Berenson GS, Radhakrishnamurthy B, Srinivasan SR, Vijayagopal P, Dalferes ER, Sharma C: Recent advances in molecular pathology. Carbohydrate-protein macromolecules and arterial wall integrity-A role in atherogenesis. Exp Mol Patho 41:267-287, 1984.
72. Wight TN: Cell biology of arterial proteoglycans. Arteriosclerosis 9:1-20, 1989.
73. Ruoslahti E, Hayman EG, Pierschbacher MD: Extracellular matrices and cell adhesion. Arteriosclerosis 5:581-594, 1985.
74. Tanganelli P, Bianciardi G, Carducci A, Palummo N, Simoes C, Tarabochia B, Weber G, Verzuri MS, Auteri A: Updating on in-vivo and in-vitro effects of heparin and other glycosaminoglycans (mesoglycan) on arterial endothelium: a morphometrical study. Int J Tissue React 14:149-153, 1992.
75. Ramasamy S, Boissonneault GA, Lipke DW, Hennig B: Proteoglycans and endothelial barrier function: effect of linoleic acid exposure to porcine pulmonary artery endothelial cells. Atherosclerosis 103:279-290, 1993.
76. Fujiwara S, Wiedemann H, Timpl R, Lustig A, Engel J: Structure and interactions of heparan sulfate proteoglycans from a mouse tumor basement membrane. Eur J Biochem 143:145-157, 1984.
77. Kleinman HK, McGarvey ML, Hassell JR, Martin GR: Formation of a supramolecular complex is involved in the reconstitution of basement membrane components. Biochemistry 22:4969-4974, 1983.
78. Fransson LA, Carlstedt I, Coster L, Malmstrom A: Proteopheparan sulfate from human skin fibroblasts. Evidence for selfinteraction via the heparan sulfate side chains. J Bioi Chern 258:14342-14345, 1983.
79. Hennig B, Enoch C, Chow CK: Protection by vitamin E against endothelial cell injury by linoleic acid hydroperoxides. Nutr Res 7:1253-1260, 1987.
80. Wardle EN: Vascular permeability in diabetics and implications for therapy. Diabetes Res Clin Pract 23:135-139, 1994.
81. Ramasamy S, Lipke DW, Boissonneault GA, Guo H, Hennig B: Oxidized lipid-mediated alterations in proteoglycan metabolism in cultured pulmonary endothelial cells. Atherosclerosis 120:199-208, 1996.
82. Hennig B, Honchel R, Goldblum SE, McClain CJ: Tumor necrosis factor-mediated hypoalbuminemia in rabbits. J Nutr 118: 1586-1590, 1988.
83. Goldblum SE, Hennig B, Jay M, Yoneda K, McClain CJ: Tumor necrosis factor a-induced pulmonary vascular endothelial injury. Infect Immun 57: 1218-1226, 1989.
84. Hennig B, Diana IN, Toborek M, McClain CJ: Influence of nutrients and cytokines on endothelial cell metabolism. J Am Coli Nutr 13:224-231, 1994.
85. Ramasamy S, Lipke DW, McClain CJ, Hennig B: Tumor necrosis factor reduces proteoglycan synthesis in cultured endothelial cells. J Cell Physiol 162:119-126, 1995.
86. Esterbauer H, Gebicki J, Puhl H, JUrgens G: The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad Bioi Med 13:341-390, 1992.
87. Faruqi R, de la Motte C, DiCorleto PE: a-Tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest 94:592, 1994.
88. Offermann MK, Medford RM: Antioxidants and atherosclerosis: a molecular perspective. Heart Dis Stroke, 3:52-57, 1994.
89. Machlin U, Bendich A: Free radical tissue damage: protective role of antioxidant nutrients. FASEB J 1:441-445, 1987.
90. Niki E: Antioxidants in relation to lipid peroxidation. Chern Phys Lipids 44:227-253, 1987.
91. DiMascio P, Murphy ME, Sies H: Antioxidant defense systems: the role of carotenoids, tocopherols, and thiols. Am J Clin Nutr 53:1945-2005, 1991.
92. Chow CK: Vitamin E and oxidative stress. Free Rad Bioi Med 11:215-232, 1991.
93. Gavino VC, Miller IS, Ikharebha SO, Milo GE, Cornwell DG: Effect of polyunsaturated fatty acids and antioxidants on lipid peroxidation in tissue cultures. J Lipid Res 22:763-769, 1981.
94. Erin AN, Spirin MM, Tabidza LV, Kagan VE: Formation of alpha-tocopherol complexes with fatty acids: a hypothetical mechanism of stabilization of biomembranes by vitamin E. Biochim Biophys Acta 774:96-102, 1984.
95. Gey KF, Puska P, Jordan P, Moser UK: Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 53:326S-334S, 1991.
96. Kok FJ, van Poppel G, Meise J, Verheul E, Schouten EG, Kruyssen DHCM, Hofman A: Do antioxidants and polyunsaturated fatty acids have a combined association with coronary atherosclerosis? Atherosclerosis 31:85-90, 1991.
97. Manson JE, Gaziano JM, Jonas MA, Hennekens CH: Antioxidants and cardiovascular disease: a review. J Am Coli Nutr 12:426-432, 1993.
98. Hennig B, Boissonneault GA, Chow CK, Wang Y, Matulionis DH, Glauert HP: Effect of vitamin E on linoleic acid-mediated induction of peroxisomal enzymes in cultured porcine endothelial cells. J Nutr 120:331-337, 1990.
99. Hennig B, Boissonneault GA, Fiscus U, Marra ME: Effect of vitamin E on oxysterol-and fatty acid hydroperoxide-induced changes of repair and permeability properties of cultured endothelial cell monolayers. Internal J Vit Nutr Res 58:41-47, 1988.
100. Block ER: Hydrogen peroxide alters the physical state and function of the plasma membrane of pulmonary artery endothelial cells. J Cell Physiol 46:362-369, 1991.
101. Kunisaki M, Umeda F, Inoguchi T, Nawata H: Vitamin E binds to specific binding sites and enhances prostacyclin production by cultured aortic endothelial cells. Thromb Haemost 68:744-751, 1992.
102. Okuma M, Takayama H, Uchino H: Generation of prostacyclinlike substance and lipid peroxidation in vitamin E-deficient rats. Prostaglandins 19:527-536, 1980.
103. Chan AC, Leith MK: Decreased prostacyclin synthesis in vitamin E-deficient rabbit aorta. Am J Clin Nutr 34:2341-2347, 1981.
104. Kunisaki M, Umeda F, Inoguchi T, Nawata H: Vitamin E restores reduced prostacyclin synthesis in aortic endothelial cells cultures with a high concentration of glucose. Metabolism 41:613-621, 1992.
105. Wang J, Zheu E, Guo Z, Lu Y: Effect of hyperlipidemic serum on lipid peroxidation, synthesis of prostacyclin and thromboxane by cultured endothelial cells: protective effect of antioxidants. Free Rad Bioi Med 7:243-249, 1989.
106. Esterbauer H, Dieber-Rotheneder M, Striegl G, Waeg G: Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr 53:314S-321S, 1991.
107. Dieber-Rotheneder M, Puhl H, Waeg G, Striegl G, Esterbauer H: Effect of oral supplementation with D-et-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res 32:1325-1332, 1992.
108. Belcher ID, Balla J, Balla G, Lacobs DR, Gross M, laboc HS, Vercellotti GM: Vitamin E, LDL, and endothelium. Brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro. Arterioscler Thromb 13:1779-1789, 1993.
109. lanero DR: Therapeutic potential of vitamin E in the pathogenesis of spontaneous atherosclerosis. Free Rad Bioi Med 11:129-144, 1991.
110. Bettger WI, O'Dell BL: A critical physiological role of zinc in the structure and function of biomembranes, Life Sci 28: 1425-1438, 1981
111. Vallee B, Falchuk KH: The biochemical basis of zinc physiology. Physiol Rev 73:79-118, 1993.
112. Ludwig JC, Chvapil M: Reversible stabilization of liver lysosomes by zinc ions. J Nutr 110:945-953, 1980.
113. Pfeiffer CJ, Cho CH: Modulating effect of zinc on hepatic lysosomal fragility induced by surface-active agents. Res Comm Chern Path Pharmacol 27:587-598, 1980.
114. Oteiza PI, Olin KL, Fraga CG, Keen CL: Zinc deficiency causes oxidative damage to proteins, lipids and DNA in rat testes. J Nutr 125:823-829, 1995.
115. Bray TM, Bettger WI: The physiological role of zinc as an antioxidant. Free Rad Bioi Med 8:281-291, 1990.
116. Bunk MJ, Dnistrian AM, Schwartz MK, Rivlin RS: Dietary zinc deficiency decreases plasma concentrations of vitamin E. Proc Soc Exp BioI Med 190:379-384, 1989.
117. Wilkins GM, Leake DS: The oxidation of low density lipoprotein by cells or iron is inhibited by zinc. FEBS Lett 341:259-262, 1994.
118. Hennig B, McClain CR, Wang Y, Vasudeva N, Ramasamy S: Zinc protects against linoleic acid-induced disruption of endothelial barrier function in culture. J Am Coli Nutr 9:535, 1990.
119. Hennig B, Wang Y, Ramasamy S, McClain CJ: Zinc protects against tumor necrosis factor-induced disruption of porcine endothelial cell monolayer integrity. J Nutr 123:1003-1009, 1993.
120. Taubeneck MW, Daston GP, Rogers JM, Gershwin ME, Ansari A, Keen CL: Tumor necrosis-a alters maternal and embryonic zinc metabolism and is developmentally toxic in mice. J Nutr 125:908-919, 1995.
121. Hennig B, Wang Y, Ramasamy S, McClain CJ: Zinc deficiency alters barrier function of cultured porcine endothelial cells. J Nutr 122:1242-1247, 1992.
122. Clair J, Talwalkar R, McClain CR, Hennig B: Selective removal of zinc from cell culture media. 1 Trace Elem Exp Med 7:143-151, 1995.
123. Suttorp N, Toepfer W, Roka L: Antioxidant defense mechanisms of endothelial cells: glutathione redox cycle versus catalase. Am J Physiol 252:C671-e680, 1986.
124. Beutler E: Nutritional and metabolic aspects of glutathione. Ann Rev Nutr 9:287-302, 1989.
125. Nemeth I, Boda D: The ratio of oxidized/reduced glutathione as an index of oxidative stress in various experimental models of shock syndrome. Biomed Biochim Acta 48:S53-S57, 1989.
126. Toborek M, Hennig B: Fatty acid-mediated effects on the glutathione redox cycle in cultured endothelial cells. Am J Clin Nutr 59:60-65, 1994.
127. Deneke SM, Fanburg BL: Regulation of cellular glutathione. Am J Physiol 252:L163-L173, 1989.
128. Israel N, Gougerot-Pocidalo MA, Aillet F, Virelizier JL: Redox status of cells influences constitutive or induced NF-KB translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J Immunol 149:3386-3393, 1992.
129. Pan M, Fisher CP, Wasa M, Lukaszewicz G, Stevens BR, Bode BP, Abcouwer SF, Souba WW: Amino acid metabolism and the vascular endothelium: regulation and disease implications. Shock 4:79-88, 1995.
130. Tsan M-F, White IE, Rosano CL: Modulation of endothelial GSH concentrations: effect of exogenous GSH and GSH monoethyl ester. J Appl Physiol 66:1029-1034, 1989.
131. Butterworth M, Upshall DG, Hobbs M, Cohen GM: Elevation of cysteine and replenishment of glutathione in rat lung slices by cysteine isopropylester and other cysteine precursors. Biochem Pharmacol 45:1769-1774, 1993.
132. Horton JK, Meredith MI, Bend JR: Glutathione biosynthesis from sulfur-containing amino acids in enriched populations of Clara and type II cells and macrophages freshly isolated from rabbit lung. J Pharrnacol Exp Ther 240:376-380, 1987.
133. Cotgreave IA, Constantin-Teodosiu D, Moldeus P: Nonxenobiotic manipulation and sulfur precursor specificity of human endothelial glutathione. J Appl Physiol 70:1220-1227, 1991.
134. Gorman LS, Toborek M, Hennig B: Cysteine deficiency potentiates fatty acid-mediated oxidative stress in cultured endothelial cells. Biochem Arch 11:211-219, 1995.
135. Suttorp N, Kastle S, Neuhof H: Glutathione redox cycle is an important defense system of endothelial cells against chronic hyperoxia. Lung 169:203-214, 1991.
136. Sala R, Moriggi E, Corvasce G, Morelli D: Protection by Nacetylcysteine against pulmonary endothelial cell damage induced by oxidant injury. Eur Respir J 6:440-446, 1993.
137. Das SK, White AC, Fanburg BL: Modulation of transforming growth factor-beta 1 antiproliferative effects on endothelial cells by cysteine, cystine, and N-acetylcysteine. J Clin Invest 90:1649-1656, 1992.
138. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM: Vascular cell adhesion molecule-l (VCAM-l) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 92:1866-1874, 1993.